Zobrazeno 1 - 10
of 1 093
pro vyhledávání: '"59"'
Autor:
M. Karanth, A. Fowler, Benjamin J Uttenthal, L. Cooke, V. Shyamsundar, S. Docherty, K. Maw, A. Hodson, C. Saha, Nimish Shah, J. Russell, A. Collins, S. Sadullah, George A. Follows, Amy A Kirkwood, Nicholas Francis Grigoropoulos
Publikováno v:
Hematological Oncology. 35:318-319
Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53
Autor:
Zhi-Yu Wang, Rongfeng Liu, Hongchen Li, Jian Shi, Yanzhao Xu, Xing Li, Junfeng Liu, Yanzhi Cui, Xiaojin Guo
Publikováno v:
Oncology Letters
Human esophageal cancer (hESC) cell motility adopts various modes, resulting in hESC progression and poor survival. However, how tripartite motif 59 (TRIM59), as the ubiquitination machinery, participates in hESC metastasis is not completely understo
Autor:
Gesina van Lijnschoten, Clément J. Huysentruyt, Max J. Lahaye, Maartje Los, Jacobus W. A. Burger, Joost Nederend, Robin J. Lurvink, Djamila Boerma, Simon W. Nienhuijs, Marinus J. Wiezer, Geert-Jan Creemers, Emma C. E. Wassenaar, Maarten J. Deenen, Ignace H. J. T. de Hingh, Koen P. Rovers
Publikováno v:
Annals of Surgical Oncology, 28(9), 5311-5326. Springer, Cham
Background Despite its increasing use, pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-OX) has never been prospectively investigated as a palliative monotherapy for colorectal peritoneal metastases in clinical trials. This tr
Autor:
Hiroki Ishihara, Takashi Ikeda, Hiroaki Shimmura, Toshio Takagi, Hideki Ishida, Kazunari Tanabe, Junpei Iizuka, Kazutaka Nakamura, Hidekazu Tachibana, Kazuhiko Yoshida, Hirohito Kobayashi, Hironori Fukuda, Yasunobu Hashimoto, Tsunenori Kondo, Yuki Nemoto
Publikováno v:
Targeted Oncology. 16:493-502
It remains unclear how early treatment interruption of nivolumab plus ipilimumab due to immune-related adverse events affects the outcome of previously untreated metastatic renal cell carcinoma (mRCC). To investigate the prognostic impact of the earl
Autor:
Qiong Fu, Ping Feng, Ling-Yun Sun, Xiao-Xia Zuo, Dong-Bao Zhao, Dong-Yi He, Hua-Xiang Wu, Wei Zhang, Fang Du, Chun-De Bao, Li-Shao Guo.
Publikováno v:
Chinese Medical Journal
Chinese Medical Journal, Vol 134, Iss 12, Pp 1457-1464 (2021)
Chinese Medical Journal, Vol 134, Iss 12, Pp 1457-1464 (2021)
Background:. Clinical observational studies revealed that 99Tc-methylene diphosphonate (99Tc-MDP) could reduce joint pain and swollenness in rheumatoid arthritis (RA) patients. This multicenter, randomized, double-blind, double-dummy study aimed to e
Publikováno v:
Journal of Surgical Research. 261:43-50
Background Monitoring of decrease in fibrinogen levels with surgical blood loss is crucial for timely transfusion of fresh frozen plasma (FFP) to avoid coagulopathic bleeding. Here, we validated a simulation model to predict hemorrhagic reductions in
Autor:
Casper H.J. van Eijck, Anouk E J Latenstein, Marjolein Y.V. Homs, Lydia G. M. van der Geest, Bert-Jan J. ten Tije, Geert-Jan Creemers, Hanneke W. M. van Laarhoven, Nadia Haj Mohammad, Johanna W. Wilmink, I. Quintus Molenaar, Judith de Vos-Geelen, Jan Willem B. de Groot, Tara M. Mackay, Marc G. Besselink
Publikováno v:
Acta oncologica (Stockholm, Sweden), 59(6), 705-712. Informa Healthcare
Acta Oncologica, 59(6), 705-712. Routledge/Taylor & Francis Group
Acta Oncologica, 59(6), 705-712. Informa Healthcare
Acta Oncologica, 59(6), 705-712. Routledge/Taylor & Francis Group
Acta Oncologica, 59(6), 705-712. Informa Healthcare
Background: Positive results of randomized trials led to the introduction of FOLFIRINOX in 2012 and gemcitabine with nab-paclitaxel in 2015 for patients with metastatic pancreatic ductal adenocarcinoma. It is unknown to which extent these new chemoth
Autor:
Sherry Pierce, Musa Yilmaz, Yesid Alvarado-Valero, Marina Konopleva, Courtney D. Di Nardo, Sa A. Wang, Jeffrey L. Jorgensen, Koji Sasaki, Rebecca Garris, Farhad Ravandi-Kashani, Jan A. Burger, April Ingram, Zeev Estrov, Hagop M. Kantarjian, Maro Ohanian Do, Jorge E. Cortes, Elias Jabbour, Nicholas J. Short, William G. Wierda, Joseph D. Khoury, Nitin Jain, Naval Daver, Susan OʼBrien, Tapan M. Kadia, Guillermo Garcia-Manero
Publikováno v:
American Journal of Hematology. 95:734-739
Liposomal vincristine is designed to reduce neurotoxicity and increase dose intensity delivery, and has been approved as salvage therapy in relapsed/refractory acute lymphoblastic leukemia (ALL). Our aim was to evaluate the response rate, toxicities,
Autor:
Felix Stader, Thierry Buclin, Monia Guidi, Susana Alves Saldanha, Matthias Cavassini, Laurent A. Decosterd, Catia Marzolini, Perrine Courlet, Marcel Stoeckle, Chantal Csajka
Publikováno v:
Clinical Pharmacokinetics
Clinical pharmacokinetics, vol. 59, no. 8, pp. 1037-1048
Clinical pharmacokinetics, vol. 59, no. 8, pp. 1037-1048
Background People living with HIV (PLWH) are aging and experience age-related physiological changes and comorbidities. Atorvastatin is a widely prescribed lipid-lowering agent metabolized by cytochrome P450 (CYP) 3A4, whose hepatocyte uptake is facil
Autor:
Yasin Tuncer, Rahime Özdemir
Publikováno v:
Molecular Biology Reports. 47:1703-1712
The aim of this study was isolation and identification of the high-level aminoglycoside-resistant (HLAR) enterococci in raw milk and dairy products and to analyze their antibiotic resistance and the presence of aminoglycoside-modifying enzyme (AME) g